Sort
48,018 grants matching “immunotherapy”
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
$623,486Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2020 · CA
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
$623,480Calvin J Kuo · Stanford University · R01 · FY2024 · CA
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$623,479Michael R Wilson · University Of California, San Francisco · R01 · FY2022 · NS
Exploring CD38 molecular biology and imaging in multiple myeloma pathogenesis
$623,387Monica Shokeen · Washington University · R01 · FY2021 · CA
Clinical protocols for the treatment of gastrointestinal cancer
$623,247Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular Mechanisms of Adjuvant Triplet Combinations
$623,162Nicolas Chevrier · University Of Chicago · U01 · FY2022 · AI
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$623,127Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Immunobiology and immunotherapy of pancreatic cancer
$623,108Robert H Vonderheide · University Of Pennsylvania · R01 · FY2012 · CA
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
$623,084Vinod P Balachandran · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$623,064University Of Wisconsin Madison · U10 · FY2003 · CA
Investigational Cancer Therapeutics Training Program
$623,013Dean F. Bajorin · Sloan-Kettering Inst Can Research · T32 · FY2021 · CA
Metallo-fluorocarbon nanoemulsion for PET detection of cancer inflammation
$622,917Eric T Ahrens · University Of California, San Diego · R01 · FY2024 · CA
Computational analysis of tumor ecosystems and their regulation and association with outcomes
$622,806Andrew J. Gentles · Stanford University · R01 · FY2023 · CA
Influences of the Microenvironment on Cancer Stem Cells
$622,787Hong Wu · University Of California Los Angeles · U01 · FY2011 · CA
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
$622,641Arvin Dar · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
UBR5's mechanisms of action in tumorigenesis and immunoregulation
$622,468Xiaojing Ma · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Phase I Clinical Trials of Anticancer Agents
$622,307Mayo Clinic · U01 · FY2004 · CA
IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors
$622,304Andras A. Heczey · Baylor College Of Medicine · R01 · FY2023 · CA
Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays
$622,286Stephen R. Bowen · University Of Washington · R01 · FY2022 · CA
The nose-lung cross talk in upper respiratory virus infection induced asthma exacerbations
$622,240Xiaoyang Hua · University Of Iowa · R01 · FY2023 · HL
Administrative Supplement for Emory SeroNet "Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity"
$622,147Ignacio E. Sanz · Emory University · U54 · FY2024 · CA
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
$622,068Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2022 · CA
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment
$622,059Richard T Lee · Beckman Research Institute/City Of Hope · U01 · FY2023 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$622,000Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery
$621,942Franklin D West · University Of Georgia · R01 · FY2025 · NS